| Literature DB >> 15566598 |
Jan J De Waele1, Eric Hoste, Stijn I Blot, Uwe Hesse, Piet Pattyn, Bernard de Hemptinne, Johan Decruyenaere, Dirk Vogelaers, Francis Colardyn.
Abstract
INTRODUCTION: There is evidence that postponing surgery in critically ill patients with severe acute pancreatitis (SAP) leads to improved survival, but previous reports included patients with both sterile and infected pancreatic necrosis who were operated on for various indications and with different degrees of organ dysfunction at the moment of surgery, which might be an important bias. The objective of this study is to analyze the impact of timing of surgery and perioperative factors (severity of organ dysfunction and microbiological status of the necrosis) on mortality in intensive care unit (ICU) patients undergoing surgery for SAP.Entities:
Mesh:
Year: 2004 PMID: 15566598 PMCID: PMC1065077 DOI: 10.1186/cc2991
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Characteristics, indications for surgery and outcome of patients operated on for severe acute pancreatitis (n = 56)
| Parameter | Early surgerya ( | Late surgerya ( | |
| Patient characteristics | |||
| Age, years (mean ± SD) | 54 ± 14.8 | 56 ± 12.8 | 0.58 |
| Male sex | 16 (72.7%) | 19 (55.9%) | 0.20 |
| APACHE II score (mean ± SD) | 22 ± 12.1 | 19 ± 8.9 | 0.47 |
| Ranson score (mean ± SD) | 6.2 ± 2.46 | 5.8 ± 1.80 | 0.59 |
| Sterile necrosis at first surgical intervention | 13 (59.1%) | 17 (50%) | 0.50 |
| Interval from diagnosis to surgery, days (median and IQR) | 5 (3–9) | 20 (17–31) | <0.001 |
| SOFA score at surgical intervention (median and IQR) | 4 (2–8) | 4 (2–8) | 0.78 |
| Indications for surgery | |||
| Documented infection of pancreatic necrosis | 5 (22.7%) | 14 (41.2%) | 0.25 |
| Deteriorating clinical condition | 9 (40.9%) | 3 (8.8%) | 0.007 |
| Unresolving pancreatitis or suspected infection of pancreatic necrosis | 8 (36.4%) | 17 (50%) | 0.41 |
| Outcome | |||
| LOS in ICU, days (median and IQR) | 14 (5–33) | 14 (6–35) | 0.75 |
| LOS in hospital, days (median and IQR) | 29 (15–58) | 87 (54–106) | <0.001 |
| LOS in ICU in hospital survivors, days (median and IQR)b | 16 (4–46) | 12 (5–31) | 0.92 |
| LOS in hospital in hospital survivors, days (median and IQR)b | 44 (30–107) | 88 (60–106) | 0.034 |
| Mortality | 12 (54.5%) | 10 (29.4%) | 0.06 |
APACHE II score, Acute Physiology And Chronic Health Evaluation II score; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay; SOFA, sepsis-related organ failure assessment.
aEarly surgery was defined as surgery within the first 12 days after admission.
bEarly surgery, n = 10; late surgery, n = 24.
Microorganisms (n = 36) isolated from 26 patients with infected pancreatic necrosis
| Microorganism | |
| Gram-positive bacteria | 14 |
| | 4 |
| | 4 |
| Enterococci | 6 |
| Gram-negative bacteria | 14 |
| | 7 |
| | 4 |
| | 1 |
| | 1 |
| | 1 |
| Fungi | 7 |
| | 7 |
| Anaerobes | 1 |
| Bacteroides | 1 |
Comparison of patients with infected and sterile pancreatic necrosis
| Characteristic | Infected pancreatic necrosis ( | Sterile pancreatic necrosis ( | |
| Age, years (mean ± SD) | 56 ± 13.6 | 55 ± 13.7 | 0.75 |
| Male gender | 18 (78%) | 17 (57%) | 0.33 |
| APACHE II score (mean ± SD) | 20 ± 9.7 | 21 ± 11.1 | 0.71 |
| CRP at admission, mg/dl (mean ± SD) | 17 ± 14.7 | 16 ± 15.8 | 0.87 |
| Ranson score (mean ± SD) | 6.2 ± 1.7 | 5.7 ± 2.3 | 0.50 |
| Organ failure | |||
| Respiratory insufficiency | 19 (7%) | 24 (80%) | 0.54 |
| Acute renal failure | 15 (58%) | 24 (80%) | 0.07 |
| Cardiovascular failure | 21 (81%) | 20 (67%) | 0.12 |
| Interval from diagnosis to surgery, days (median and IQR) | 14 (6–24) | 18 (6–31) | 0.36 |
| LOS in ICU, days (median and IQR) | 14 (5–32) | 12 (5–30) | 0.86 |
| LOS in hospital, days (median and IQR) | 68 (44–90) | 54 (19–97) | 0.36 |
| Mortality | 5 (19%) | 17 (57%) | 0.004 |
APACHE II score, Acute Physiology And Chronic Health Evaluation II score; CRP, C-reactive protein; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay.
Comparison of survivors and non-survivors (n = 56)
| Characteristic | Non-survivors ( | Survivors ( | |
| Age, years (mean ± SD) | 62 ± 12.0 | 51 ± 12.8 | 0.002 |
| APACHE II score (mean ± SD) | 25 ± 8.5 | 18 ± 10.6 | 0.019 |
| Ranson score (mean ± SD) | 6.3 ± 2.03 | 5.7 ± 2.09 | 0.36 |
| Male gender | 15 (68%) | 20 (59%) | 0.48 |
| CRP at admission, mg/dl (mean ± SD) | 176 ± 162.3 | 170 ± 142.2 | 0.90 |
| Organ dysfunction | |||
| Respiratory insufficiency | 22 (100%) | 21 (62%) | 0.001 |
| Acute renal failure | 22 (100%) | 17 (50%) | <0.001 |
| Cardiovascular failure | 20 (91%) | 12 (35%) | <0.001 |
| Sterile necrosis | 17 (77%) | 13 (38.2%) | 0.004 |
| SOFA score at surgery (median and IQR) | 4 (9–13) | 2 (2–7) | 0.005 |
| MODS as indication for surgery | 8 (36%) | 4 (12%) | 0.045 |
| Early surgical intervention | 12 (55%) | 10 (29%) | 0.06 |
| Interval from diagnosis to surgery, days (median and IQR) | 11 (4–22) | 18 (12–29) | 0.09 |
APACHE II score, Acute Physiology And Chronic Health Evaluation II score; CRP, C-reactive protein; IQR, interquartile range; MODS, multiple organ dysfunction syndrome; SOFA, sepsis-related organ failure assessment.
Multivariate analysis
| Variable | OR | 95% CI | |
| Sterile necrosis | 0.012 | 13.704 | 1.778–105.602 |
| SOFA score at surgery (per point) | 0.009 | 1.351 | 1.076–1.695 |
| Age (per year older) | 0.004 | 1.124 | 1.037–1.218 |
| Interval from diagnosis to surgery | 0.868 | 1.006 | 0.939–1.078 |
CI, confidence interval; OR, odds ratio; SOFA, sepsis-related organ failure assessment.